REMOVED: “Erratum to: Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial” (American Heart Journal (2012) 163(6) (938–945) (S0002870312001780) (10.1016/j.ahj.2012.03.012));Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial

American Heart Journal

Volumn 163, Issue 6, 2012, Pages 938-945

  Thiele, Holger ^a   Schuler, Gerhard ^a   Neumann, Franz Josef ^b   Hausleiter, Jörg ^c   Olbrich, Hans Georg ^d   Schwarz, Bettina ^e   Hennersdorf, Marcus ^f   Empen, Klaus ^g   Fuernau, Georg ^a   Desch, Steffen ^a   De Waha, Suzanne ^a   Eitel, Ingo ^a   Hambrecht, Rainer ^h   Böhm, Michael ⁱ   Kurowski, Volkhard ^j   Lauer, Bernward ^k   Minden, Hans Heinrich ^l   Figulla, Hans Reiner ^m   Braun Dullaeus, Rüdiger C ⁿ   Strasser, Ruth H ^o   Rochor, Kristin ^p   Maier, Sebastian K G ^q   Möllmann, Helge ^r   Schneider, Steffen ^s   Ebelt, Henning ^t   Werdan, Karl ^t   Zeymer, Uwe ^s,u   more..

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Asklepios Clinic Langen Seligenstadt   (Germany)

^e Segeberger Kliniken   (Germany)

^f SLK Kliniken Heilbronn   (Germany)

^g UNIVERSITY OF GREIFSWALD   (Germany)

^h Klinikum Links der Weser   (Germany)

ⁱ SAARLAND UNIVERSITY   (Germany)

^j UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^k ZENTRALKLINIK BAD BERKA   (Germany)

^l Oberhavel Kliniken GmbH   (Germany)

^m FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

ⁿ OTTO VON GUERICKE UNIVERSITY   (Germany)

^o DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^p SANA KLINIKUM OFFENBACH   (Germany)

^q UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^r KERCKHOFF HEART CENTER   (Germany)

^s Institut fur Herzinfarktforschung Ludwigshafen   (Germany)

^t MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^u Heart Center Ludwigshafen   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; PRASUGREL; TICAGRELOR;

ACUTE HEART INFARCTION; ADULT; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY RECANALIZATION; COUNTERPULSATION; FOLLOW UP; HEART HEMODYNAMICS; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPOTHESIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; STROKE;

EID: 84862070478     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.11.001     Document Type: Erratum

References (30)

1. Babaev A, Frederick PD, Pasta DJ, et al. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005;294:448-54. (Pubitemid 41124177)
2. Goldberg RJ, Spencer FA, Gore JM, et al. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 2009;119:1211-9.
3. Jeger RV, Radovanovic D, Hunziker PR, et al. Ten-year incidence and treatment of cardiogenic shock. Ann Intern Med 2008;149:618-26.
4. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. Circulation 2004;110:588-636.
5. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent STsegment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909-45.
6. Sjauw KD, Engstrom AE, Vis MM, et al. A systematic review and meta-analysis of intra aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 2009;30:459-68.
7. Barron HV, Every NR, Parsons LS, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 2001;141:933-9.
8. Bengtson JR, Kaplan AJ, Pieper KS, et al. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol 1992;20:1482-9. (Pubitemid 23007500)
9. Prondzinsky R, Lemm H, Swyter M, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock-the prospective, randomized IABP SHOCK Trial for attenuation of multi-organ dysfunction syndrome. Crit Care Med 2010;38:152-60.
10. Thiele H, Allam B, Chatellier G, et al. Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J 2010;31:1828-35.
11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
12. Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J 2009;30:2102-8.
13. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999;341:625-34.
14. Thiele H, Lauer B, Hambrecht R, et al. Reversal of cardiogenic shock by percutaneous left-atrial-to-femoral arterial bypass assistance. Circulation 2001;104:2917-22. (Pubitemid 33139103)
15. Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intraaortic balloon support versus a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005;26:1276-83. (Pubitemid 41435457)
16. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Circulation 2007;116:2634-53. (Pubitemid 350182388)
17. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
18. Stone GW, Ohman EM, Miller MF, et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry. J Am Coll Cardiol 2003;41:1940-5. (Pubitemid 36677111)
19. The TRIUMPH Investigators. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock. The TRIUMPH randomized controlled trial. JAMA 2007;297:1657-66.
20. Pocock SJ. Current issues in the design and interpretation of clinical trials. Br Med J (Clin Res Ed) 1985;290:39-42. (Pubitemid 15075985)
21. Werdan K, Ruß M, Buerke M, et al. German-Austrian S3-guideline: diagnosis, monitoring, and therapy of cardiogenic shock due to myocardial infarction. Intensivmed 2011;48:291-344.
22. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010;31:2501-55.
23. De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010;362:779-89.
24. Wilson SR, Mudge Jr GH, Stewart GC, et al. Evaluation for a ventricular assist device: selecting the appropriate candidate. Circulation 2009;119:2225-32.
25. den Uil CA, Lagrand WK, van der Ent M, et al. Impaired microcirculation predicts poor outcome of patients with acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2010;31:3032-9.
26. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-56. (Pubitemid 10242750)
27. Ukoumunne OC, Gulliford MC, Chinn S, et al. Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technol Assess 1999;3:iii-92.
28. Thiele H, Smalling RW, Schuler G. Percutaneous left ventricular assist devices in cardiogenic shock. Eur Heart J 2007;28:2057-63.
29. Mehta RH, Lopes RD, Ballotta A, et al. Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease? Am Heart J 2010;159:141-7.
30. White HD, Assmann SF, Sanborn TA, et al. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) Trial. Circulation 2005;112:1992-2001. (Pubitemid 41377419)